v3.26.1
REVENUES (Tables)
6 Months Ended
Jun. 30, 2026
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue [Table Text Block]
The Company’s Revenues by segment and by payer group were as follows:
Three Months Ended June 30, 2026Three Months Ended June 30, 2025
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Dx:
   Clients22 %— %— %22 %24 %— %— %24 %
   Patients11 %— %— %11 %10 %— %— %10 %
   Medicare and Medicaid%— %— %%%— %— %%
   Third party37 %— %— %37 %36 %— %— %36 %
Total Dx revenues78 %— %— %78 %78 %— %— %78 %
BLS:
Pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs%%%22 %%%%22 %
Total Revenues
87 %%%100 %87 %%%100 %
Six Months Ended June 30, 2026Six Months Ended June 30, 2025
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Dx:
   Clients23 %— %— %23 %24 %— %— %24 %
   Patients10 %— %— %10 %10 %— %— %10 %
   Medicare and Medicaid%— %— %%%— %— %%
   Third party37 %— %— %37 %36 %— %— %36 %
Total Dx revenues78 %— %— %78 %78 %— %— %78 %
BLS:
Pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs%10 %%22 %%%%22 %
Total Revenues86 %10 %%100 %87 %%%100 %
Contract with Customer, Asset and Liability [Table Text Block]
The following table provides information about accounts receivable and unbilled services from contracts with customers:
June 30, 2026December 31, 2025
Dx accounts receivable$1,546.6 $1,349.0 
BLS accounts receivable833.0 791.2 
Less: BLS allowance for credit losses(37.2)(36.4)
Accounts receivable, net$2,342.4 $2,103.8 
Gross unbilled services$165.9 $164.0 
Less: BLS allowance for credit losses(3.5)(7.1)
Unbilled services, net$162.4 $156.9 
Financing Receivable, Allowance for Credit Loss [Table Text Block] The rollforward for the allowance for credit losses was as follows:
Accounts Receivable, netUnbilled Services, netTotal
Allowance for credit losses at December 31, 2025
$36.4 $7.1 $43.5 
Credit loss expense4.9 — 4.9 
Write-offs(3.8)(3.6)(7.4)
Foreign currency impact
(0.3)— (0.3)
Allowance for credit losses at June 30, 2026$37.2 $3.5 $40.7